glp 1 agonisten GLP-1 Agonists - What is it? Polyagonists Enable Increasingly Effective Treatment

As of 2026, retatrutide is in Phase 3 clinical trials

The mechanism is straightforward

All findings to date derive from preclinical and early investigational data

[DOI] [PMC free article] [PubMed] [Google Scholar] 264.Matikainen N., Bogl L.H., Hakkarainen A., Lundbom J., Lundbom N., Kaprio J

Some of those lawsuits have been filed by past Wegovy patients who say the medication caused them to suffer from vision problems, and they were not aware that this was a potential side effect

Positive trial outcomes coupled with significant funding into research and development will contribute towards the swift growth of this category in the coming years